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Abstract
Recently, we identified an ADP-ribosylating and vacuolating cytotoxin in Mycoplasma pneumoniae designated Community
Acquired Respiratory Distress Syndrome (CARDS) toxin. In this study we show that vacuoles induced by recombinant CARDS
(rCARDS) toxin are acidic and derive from the endocytic pathway as determined by the uptake of neutral red and the fluid-
phase marker, Lucifer yellow, respectively. Also, we demonstrate that the formation of rCARDS toxin-associated cytoplasmic
vacuoles is inhibited by the vacuolar ATPase inhibitor, bafilomycin A1, and the ionophore, monensin. To examine the
ontogeny of these vacuoles, we analyzed the distribution of endosomal and lysosomal membrane markers during vacuole
formation and observed the enrichment of the late endosomal GTPase, Rab9, around rCARDS toxin-induced vacuoles.
Immunogold-labeled Rab9 and overexpression of green fluorescent-tagged Rab9 further confirmed vacuolar association.
The late endosomal- and lysosomal-associated membrane proteins, LAMP1 and LAMP2, also localized to the vacuolar
membranes, while the late endosomal protein, Rab7, and early endosomal markers, Rab5 and EEA1, were excluded. HeLa
cells expressing dominant-negative (DN) Rab9 exhibited markedly reduced vacuole formation in the presence of rCARDS
toxin, in contrast to cells expressing DN-Rab7, highlighting the importance of Rab9 function in rCARDS toxin-induced
vacuolation. Our findings reveal the unique Rab9-association with rCARDS toxin-induced vacuoles and its possible
relationship to the characteristic histopathology that accompanies M. pneumoniae infection.
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Introduction
Mycoplasma pneumoniae, the etiologic agent of primary atypical
pneumonia, is associated with a wide variety of respiratory
infections ranging from tracheobronchitis and pharyngitis to
extrapulmonary infections, including joint and central nervous
system disorders [1]. It is believed to be responsible for 20–30%
of all community-acquired pneumonia and is also linked to acute
and chronic airway diseases, such as bronchial asthma and
chronic obstructive pulmonary disease [2,3,4,5]. M. pneumoniae is
generally considered an extracellular pathogen that adheres to
mucosal epithelial surfaces, although it has the capability to
replicate and survive intracellularly for extended periods [6,7].
Cytadherence of M. pneumoniae to host cells is a prerequisite for
colonization and infection, which is primarily achieved through
an assemblage of proteins localized at its tip organelle [8,9,10].
However, alternate mechanisms of adherence to host cells have
been reported by us and are likely to be physiologically relevant
[11,12]. Following mycoplasma infection, the cytopathology that
M. pneumoniae elicits has historically been attributed to several
factors, including hydrogen peroxide and superoxide radicals
generated by mycoplasma metabolism, nutritional parasitism,
and the host inflammatory responses [13,14,15,16]. Earlier, we
proposed that only metabolically active mycoplasmas could
introduce toxic factors into respiratory cells resulting in tissue
injury [14].
Recently, we described a unique M. pneumoniae ADP-ribosylat-
ing and vacuolating cytotoxin designated CARDS toxin [17] that
shares sequence similarity to the known ADP-ribosylating toxin,
Bordetella pertussis pertussis toxin S1 subunit, and exhibits an ADP-
ribosyltransferase activity in the presence of host cell proteins
[12,17]. Interestingly, rCARDS toxin elicited a distinct vacuolat-
ing phenotype in cultured mammalian cell lines, which was not
exclusively dependent upon ADP-ribosylating activity [17].
CARDS toxin is the first ADP-ribosyltransferase described that
exhibits both ADP-ribosyltransferase and vacuolating activities.
rCARDS toxin-induced vacuolation appears particularly relevant
to the pathogenic process, as histopathology associated with M.
pneumoniae infection includes cellular vacuolation, marked deteri-
oration of ciliary movement, and ultimately cell death [15,18,19].
Furthermore, baboon tracheal rings exposed to rCARDS toxin
exhibited a vacuolated appearance, in addition to a reduction of
ciliary movement and loss of cellular integrity of the respiratory
epithelium [17]. Importantly, we observed characteristic vacuola-
tion of the bronchial epithelium in rCARDS toxin-treated mice
[20].
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22877Toxin-mediated vacuole formation has been extensively exam-
ined in Helicobacter pylori [21]. Its vacuolating cytotoxin, designated
VacA, induces vacuole formation upon acid activation and in the
presence of weak bases, like ammonium chloride [22,23,24].
Cellular uptake of the acidotropic dye, neutral red, revealed that
the intralumenal environment of VacA-induced vacuoles is acidic,
and further studies determined the endosomal origin of these
vacuoles [25,26,27,28]. The vacuolar membranes of VacA-
induced vacuoles were enriched in markers for late endocytic
compartments, including lysosome associated membrane protein 1
(LAMP1) and the GTPase, Rab7, but not markers for early
endocytic compartments [28]. Rab7 GTPase enrichment onto
vacuolar membranes was further linked to its role in vacuole
biogenesis [29]. Rab GTPases are key regulators of vesicle traffic
in eukaryotic cells and also play an important role in membrane
fusion events by recruiting, tethering and docking cellular factors
to target membranes. Rab GTPases delineate membrane
composition and identity, as they recruit specific effectors to
restricted membrane microdomains [30,31]. Rab5, a protein
associated with the plasma membrane and early endosomes,
regulates endocytosis at early stages [32]. Rab7 regulates transport
from early endosomes to late endosomes [33] or from late
endosomes to lysosomes [34] and is associated with vesicular-
tubular structures that develop from the perinuclear area to the
cellular periphery. Rab9 regulates membrane cycling between late
endosomes and the trans-Golgi network (TGN) and is mostly
localized to the perinuclear region [35,36]. While the literature
regarding the role of Rab GTPases in membrane trafficking is
continually evolving, it has been proposed that VacA-induced
vacuolation alters membrane traffic at the late endosomal stage, or
inhibits transport, directly or indirectly, between late endosomes
and lysosomes [29].
Vacuolation appears to be closely linked to M. pneumoniae
infection and the presence of CARDS toxin [17,20]. As CARDS
toxin does not share significant sequence similarity with known
vacuolating toxins, including VacA, we decided to investigate the
formation and composition of vacuoles generated by rCARDS
toxin. Using a panel of markers that distinguish vacuole properties,
we confirmed the association of a specific, unexpected Rab
GTPase with rCARDS toxin-induced vacuoles. Based on these
results we propose a novel mechanism of rCARDS toxin-
mediated, late endosomal vacuole biogenesis.
Results
Characterization of vacuole formation in rCARDS toxin-
treated mammalian cells
As rCARDS toxin-induced vacuolation of CHO cells was
previously demonstrated [17], we analyzed other mammalian cell
lines in order to compare the specificity and degree of
vacuolization. First, we examined human lung carcinoma
epithelial A549 cells, as M. pneumoniae is a respiratory pathogen,
and rCARDS toxin-induced vacuolation was readily evident
(Fig. 1). Other epithelial cell lines examined included kidney
(Vero) and cervical (HeLa) cell lines, which exhibited similar
vacuolization patterns. rCARDS toxin-mediated vacuolization
was dose and time-dependent in all cell lines tested with vacuole
formation occurring between 8 to 10 hours at rCARDS toxin
concentrations ranging from 5 to 75 mgm l
21. Nascent vacuoles
first appeared around the perinuclear region, followed by
increased numbers and sizes of vacuoles. Within 24 h smaller
vacuoles coalesced into larger vacuoles which could occupy the
entire cell. As the vacuoles grew in size, they retained more
neutral red, indicating their acidic nature and providing a
method to quantify rCARDS toxin-induced vacuolation (Fig. 1).
When we examined rCARDS toxin-induced vacuole formation in
the presence of the V-ATPase inhibitor, bafilomycin A1,
decreased neutral red uptake (NRU) correlated with increased
concentrations of bafilomycin A1 (Fig. 1). This observation
indicated that rCARDS toxin-mediated vacuolation was depen-
dent on V-ATPase enzymes, which are found on the membranes
of intracellular organelles, like endosomes and lysosomes.
Similarly, decreased NRU was observed in the presence of the
ionophore, monensin, reinforcing the acidic intracellular pH of
the vacuoles and suggesting an endocytic origin of vacuole
formation (Fig. 1).
rCARDS toxin-induced vacuoles originate along the
endocytic pathway
rCARDS toxin-induced vacuoles in HeLa cells accumulate the
extracellular fluid-phase marker, Lucifer yellow, indicating that
these vacuoles derive from the endocytic pathway (Fig. 2).
Fluorescence intensity varied among rCARDS toxin-induced
vacuoles, with the majority of smaller vacuoles (98%) exhibiting
the most intense fluorescence. In the presence of the cytoskeletal
inhibitors, nocodazole and colchicine, toxin-induced vacuolation
was markedly reduced at 24 h, as NRU measurements were 4%
and 12% of toxin-treated ‘control’ cells, respectively.
Enrichment of the late endosomal Rab9 GTPase around
rCARDS toxin-induced vacuoles
As rCARDS toxin-induced vacuoles appear to derive from the
endocytic pathway, we examined individual vacuoles for the
presence of endosomal and lysosomal markers including Rab5,
EEA1, Rab7, Rab9, cathepsin D, LAMP1 and LAMP2 using
indirect immunofluorescence. The early endocytic specific mar-
kers, Rab5 GTPase and EEA1, were distributed throughout the
vacuolated cells in a dispersed pattern with no evidence of selective
association with rCARDS toxin-induced vacuoles (Fig. 3). Also,
vacuolar membranes did not exhibit discernible selective labeling
with the late endosomal GTPase, Rab7. Interestingly, we observed
intense enrichment of the late endosomal Rab9 GTPase, as well as
LAMP1 and LAMP2, around rCARDS toxin-induced vacuolar
membranes (Fig. 3). Since LAMP1 and LAMP2 are known to
shuttle between lysosomes, endosomes and the plasma membrane,
and since we did not observe an association of rCARDS toxin-
induced vacuolar membranes with the lysosomal hydrolase
cathepsin D (data not shown), we focused on the late endoso-
mal-specific Rab9 GTPase. We examined whether the enriched
Rab9 GTPase around rCARDS toxin-induced vacuoles was due
to its overexpression or redistribution by comparing it with
another late endosomal marker, Rab7. rCARDS toxin-treated and
untreated HeLa cells were analyzed by immunoblot using anti-
Rab9 antibodies (Fig. 4). We did not observe increased expression
of Rab9 (or Rab7 as negative control) in vacuolated cells at
different time points, indicating that the accumulation of Rab9
around rCARDS toxin-induced vacuoles was likely due to
redistribution, rather than its increased synthesis during intoxica-
tion and vacuole development.
Distribution and localization of Rab9 at rCARDS toxin-
induced vacuolar membranes
Early rCARDS toxin-induced vacuoles were generally delin-
eated by a single bounding membrane, which supported their
endocytic origin. Vacuolar fusion events were also observed,
accounting for the large size of several vacuoles (5 mm) and
leading to their occasional occupation of the entire cell.
M. pneumoniae CARDS Toxin-Induced Vacuoles Origin
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nogold-labeled Rab9 was clearly embedded around the margins
of CARDS toxin-induced vacuoles (Fig. 5), while immunogold-
labeled Rab7 was rarely associated with the vacuolar membranes
(Fig. 5). This observation reinforced the specificity of Rab9
binding to toxin-induced vacuoles. Also, gold-conjugated second-
Figure 1. rCARDS toxin-induced vacuolation in mammalian cell lines. (A) A549, HeLa, CHO, and Vero cell monolayers were treated with
rCARDS toxin for 24 h at 37uC and images captured Neutral Red Uptake (NRU) by rCARDS toxin-induced HeLa cell vacuoles was observed. Original
magnification: 6400. (B) HeLa cells were treated with rCARDS toxin for 24 h at 37uC, and representative images of neutral red-treated cells were
compared. Note the diversity of vacuole sizes. (C) HeLa cells pretreated with varying concentrations of bafilomycin A1 or monensin were incubated
with rCARDS toxin for 24 h at 37uC. Neutral red in vacuoles was quantified by OD550 nm and expressed as percentage of control cells. All values are
the mean of two different experiments run in triplicate 6 SD (DeltaGraph).
doi:10.1371/journal.pone.0022877.g001
Figure 2. Localization of Lucifer yellow in rCARDS toxin-induced vacuolated HeLa cells. HeLa cells were intoxicated with rCARDS toxin in
the presence of 500 mgm l
21 Lucifer yellow in MEM medium for 24 h at 37uC. Cells were fixed and visualized by visible light and fluorescence
microscopy. (A) DIC; (B) Fluorescence; and (C) Merged image. Lucifer yellow is clearly discernible in a subpopulation of vacuoles (Panel C; see arrows).
Original magnification: 6400.
doi:10.1371/journal.pone.0022877.g002
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further supported the unique vacuolar association of Rab9 (data
not shown).
Rab9 is required for rCARDS toxin-induced vacuole
formation
To further confirm the association of rCARDS toxin-induced
vacuoles with Rab9, HeLa cells were transiently transfected with
either green fluorescent-tagged Rab9 or Rab7 GTPases. We
observed the clustering of GFP-Rab9 around vacuolar membranes
in intoxicated cells, in contrast to non-intoxicated HeLa cells
where GFP-Rab9 was distributed evenly throughout the cytoplasm
(Fig. 6). To further delineate the role of Rab9 in vacuole
formation, HeLa cells were transiently transfected with
mCherry-tagged DN-Rab9. The majority of cells expressing
DN-Rab9 lacked visible vacuole development (Fig. 6) supporting
the role of Rab9 in rCARDS toxin-mediated vacuole formation.
Conversely, HeLa cells expressing DN-Rab7 behaved similarly to
toxin-treated, non-transfected cells. In other words, DN-Rab7
transfected cells exhibited rCARDS toxin-induced vacuolation
(Fig. 6), which is consistent with the minor or indeterminate role of
Rab7 in toxin-induced vacuoles.
Figure 3. Indirect immunofluoresence analysis of endosomal and lysosomal markers localized to rCARDS toxin-induced vacuoles.
Untreated and rCARDS toxin-treated HeLa cells were incubated for 24 h at 37uC and processed as described in Materials and Methods. Representative
DIC and fluorescence images of untreated and intoxicated cells are shown. Note that Rab9, LAMP1 and LAMP2 antibodies react with perinuclear
region-associated vesicles in untreated cells (left panels) while in intoxicated cells Rab9, LAMP1 and LAMP2 localize and concentrate around specific
vacuoles (right panels). Original magnification: 6400.
doi:10.1371/journal.pone.0022877.g003
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M. pneumoniae infection is associated with cellular vacuolation,
marked deterioration of ciliary movement and ultimately cell
death [4,15]. Interestingly, rCARDS toxin can substitute for live
M. pneumoniae organisms in eliciting the characteristic airway
histopathology in intoxicated mice [20] and tracheal organ
cultures [17]. Similarly, rCARDS toxin induces extensive vacuole
formation in vitro in cultured mammalian cell lines (Fig. 1). These
vacuoles initially form around the perinuclear region, fuse, and
grow in size until much of the cytoplasm is occupied by a single
vacuole or several large vacuoles (Fig. 1). This process would
require the progressive addition of membranes, which is consistent
with the alteration of membrane trafficking along the endocytic-
endosomal pathway. As bacterial toxins have been extremely
useful in the study of different aspects of cell biology, the aim of
this study was to characterize and elucidate the ontogeny of
rCARDS toxin-induced vacuoles.
We observed rCARDS toxin-mediated vacuole formation in
multiple cell lines and in a concentration-dependent manner.
Similar to VacA, rCARDS toxin-induced vacuoles accumulate
neutral red, indicating the acidic nature of the vacuolar lumen [27].
rCARDS toxin distinguishes itself from VacA, as it does not require
acid activation or weak bases to induce vacuolation. However,
rCARDS toxin-induced vacuolization is prevented by the vacuolar
ATPase inhibitor, bafilomycin A1 [37], similar to VacA (Fig. 1).
Both bafilomycin A1 and monensin (Fig. 1) are reported to alter
intracellular trafficking by preventing early endosome acidification
along the endocytic pathway [38,39] The mechanisms by which
both bafilomycin A1 and monensin inhibit rCARDS toxin-
mediated vacuole formation are unclear, although similar observa-
tions were reported with Escherichia coli subtilase cytotoxin [40].
Figure 4. Immunoblot analysis of cellular levels of Rab7 and Rab9 in rCARDS toxin-treated and untreated control HeLa cells. HeLa
cells were intoxicated with rCARDS toxin and incubated for 12 or 24 h at 37uC. rCARDS toxin-treated and untreated cell extracts were separated on
NuPAGE Bis-Tris 4–12% gels and transferred to nitrocellulose membranes. A) Immunoblot analysis was performed with primary antibodies against
Rab9 (mouse) and Rab7 (rabbit) and secondary goat anti-mouse and goat anti-rabbit antibodies conjugated to alkaline phosphatase. B)
Quantification of Rab7 and Rab9 band intensities was performed by scanning immunostained bands and analyzing images with KODAK Image
software.
doi:10.1371/journal.pone.0022877.g004
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The impermeable fluorescent dye, Lucifer yellow, has been used
as a marker for fluid phase endocytosis in mammalian cells and
Saccharomyces cerevisiae [41]. The accumulation of Lucifer yellow
within rCARDS toxin-induced vacuoles, especially with the
smaller vacuoles (Fig. 2) and the retention of neutral red (Fig. 1)
is similar to the H. pylori VacA vacuoles [28], revealing their
endosomal origin. As cytoskeletal structures are essential for a
number of cellular functions, including intracellular transport of
endosomes and lysosomes, we analyzed the effect of nocodazole
and colchicine on CARDS toxin-induced vacuole formation.
These agents prevent polymerization of microtubules and,
therefore, depress membrane traffic from early endosomes to late
endosomes. As noted earlier, rCARDS toxin-induced vacuoliza-
tion was markedly reduced by these drugs, further supporting the
endocytic nature of these vacuoles [42,43,44].
In both untreated and rCARDS toxin-treated cells EEA1
localized to multiple small early endosomal vesicles distributed
throughout the cytoplasm with no obvious selective enrichment to
toxin-induced vacuoles (Fig. 3). In contrast, we demonstrated that
rCARDS toxin-induced vacuolar membranes concentrated Rab9,
a small GTPase primarily associated with late endosomes (Fig. 3)
[45]. Moreover, we showed an association of LAMP1 and LAMP2
with rCARDS toxin-induced vacuolar membranes. Although
LAMP1 and LAMP2 proteins are mainly associated with
lysosomes, they also shuttle between endosomes and the plasma
membrane [46]. These data favor the possibility that rCARDS
toxin-induced vacuoles are derived from late endosomes and that
rCARDS toxin may be altering membrane trafficking at this stage.
As seen by the neutral red uptake and light microscopy, it is clear
that rCARDS toxin vacuoles originate from the perinuclear region
and are enriched with Rab9, LAMP1 and LAMP2.
Rab9 plays an essential role in rCARDS toxin-induced
vacuole formation
Interestingly, we did not observe the clustering of another small
GTPase associated with late endosomes, Rab7. This finding is in
contrast to VacA-induced vacuoles, which contained Rab7
[28,47]. The functional involvement of Rab9 on M. pneumoniae
rCARDS toxin vacuole formation was tested by overexpression of
DN-Rab9 mutants, which resulted in a significant decrease in
rCARDS toxin-induced vacuole development (Fig. 6). These data
suggest that the extensive fusion of Rab9-containing late
endosomes appears to be crucial for the formation of rCARDS
toxin-induced vacuoles. As DN-Rab7 did not interfere with the
ability of rCARDS toxin to form vacuoles, in contrast to
overexpressed DN-Rab9 (Fig. 6), Rab7 does not appear to play
a meaningful role in rCARDS toxin-induced vacuolation.
Notably, the late endosomal Rabs, Rab7 and Rab9, have different
biological functions and are not always present on the same
endosome [45]. Since rCARDS toxin selectively associates with
the late endosomal Rab9 GTPase, but not the Rab7 GTPase, we
suggest that rCARDS toxin may affect selective subpopulations of
late endosomes that are Rab9 positive and Rab7 negative.
In this study we clearly observed the association of Rab9 with
rCARDS toxin-induced vacuoles. There is increasing information
that viruses and intracellular bacterial pathogens hijack Rab
GTPases in order to enter cells through the endocytic pathway, or
recruit membranes from the ER or the Golgi apparatus to form
replicative intracellular niches [31]. The functions of the Rab
Figure 5. Localization of immunogold-labeled Rab9 to rCARDS toxin-induced vacuoles. CARDS toxin-treated and untreated HeLa cells
were incubated for 24 h at 37uC, then labeled with primary antibodies reactive against Rab9 (mouse) or Rab7 (rabbit), followed by goat anti-mouse or
goat anti-rabbit IgG gold complex (10 nm), respectively. Representative circles indicate heavy concentration of immunogold labeled Rab9 particles
localized to vacuolar membranes in rCARDS toxin-treated cells (A), which are absent in untreated controls. In contrast to Rab9, Rab7 is observed very
rarely around the vacuoles in toxin treated vesicles (B). Bar, 100 nm. Original magnification: 680,000.
doi:10.1371/journal.pone.0022877.g005
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intracellular growth. Numerous studies have shown that selective
inclusion or retention of Rab GTPases on vacuolar membranes
regulates the biogenesis of phagosomes inhabited by several
bacteria. H. pylori inhibits phagosome maturation by localizing
Rab7 to the bacterium-containing phagosome, while mycobacte-
ria secrete factors that prevent the acquisition of Rab7 by the
phagosome, leading to enhanced intracellular survival [30,48,49].
Salmonella typhimurium acquires multiple Rabs within Salmonella-
containing vacuoles and Salmonella-induced filaments, including
Rab7 and Rab9, in order to block fusion with lysosomes and
survive intracellularly [50]. Further, it has been found that Rab9
GTPases are key components for replication of several unrelated
enveloped viruses, including HIV1, Ebola, Marburg and measles
[51]. Since viral assembly initiates at late endosomes for enveloped
viruses and viral budding is completed at the plasma membrane, it
is hypothesized that these viruses depend on Rab9 to transport
viral proteins to the TGN and out to the plasma membrane [51].
As previously mentioned, M. pneumoniae is able to establish an
intracellular residence, thereby contributing to persistence and
chronic airway infections. Whether M. pneumoniae utilizes Rab9 in
order to achieve this intracellular residence requires further
clarification. Alternatively, the endogenous proteins, TGN38 and
mannose-6 phosphate-receptor, shuttle between the late endo-
somes and the TGN, and bacterial toxins, including Pseudomonas
aeruginosa exotoxin A, have also been shown to utilize the
retrograde transport pathway through Rab9 to access the ER
[35,52]. rCARDS toxin may utilize a similar pathway by
recruiting Rab9.
With over 70 Rabs identified in the human genome, much
remains to be understood regarding the role of these regulatory
GTPases in intracellular trafficking, endosomal and phagosomal
organelles and microbial pathogenesis. Interestingly, toxins have
been helpful in the study of endocytosis and intracellular transport
[53]. Future studies with rCARDS toxin may define the molecular
mechanisms by which this unique toxin exploits Rab9 vesicles for
vacuole formation and delineate how Rab9 connects to various
components of the transport machinery, such as cargo adaptors,
molecular motors, vesicle fusion protein and other Rab GTPases.
As mentioned earlier, hallmarks of M. pneumoniae infection are
characteristic and programmed injury to respiratory cells with
accompanying histopathology and inflammatory responses. As it
became evident that rCARDS toxin was sufficient in replacing live
M. pneumoniae in the production of vacuolization, we focused on
understanding toxin-mediated vacuolating pathways. Here, we
demonstrate that rCARDS toxin-induced vacuoles originate from
late endosomal compartments and recruit the small GTP-binding
protein, Rab9, which distinguishes CARDS toxin from VacA.
Further investigation into the origin and mechanisms of CARDS
toxin-induced vacuolation may clarify the role of M. pneumoniae
and its ADP-ribosylating and vacuolating CARDS toxin in
infection and disease progression.
Materials and Methods
Chemical reagents and antibodies
Neutral red, bafilomycin A1, colchicine, nocodazole, and
monensin were purchased from Sigma and Lucifer yellow from
Figure 6. Role of Rab9 in rCARDS toxin-induced vacuoles. HeLa cells were transiently transfected with wild-type pEGFP-Rab9 or pDsRed DN-
Rab9 or pDsRed DN-Rab7 and incubated for 24 h at 37uC before addition of rCARDS toxin for an additional 24 h. rCARDS toxin-treated and untreated
HeLa cells were analyzed by light and fluorescence microscopy. (A, B) Representative DIC and fluorescence images of untreated HeLa cells transfected
with WT pEGFP-Rab9 (C, D) Representative DIC and fluorescence images of rCARDS toxin-treated HeLa cells transfected with WT pEGFP-Rab9. (E, F)
Representative fluorescence and fluorescence+DIC merged images of rCARDS toxin-treated HeLa cells transfected with pDsRed DN-Rab9. Note the
absence of vacuole formation in DN-Rab9 transfected cells (white arrows and dispersed fluorescence). Also, note distinct vacuoles in non-transfected
cells (black arrows and no fluorescence; F). (G, H) Representative fluorescence and fluorescence+DIC merged images of rCARDS toxin-treated HeLa
cells transfected with pDsRed DN-Rab7. Note cells transfected with pDsRed DN-Rab7 exhibit distinct vacuoles (H). Original magnification: 6400.
doi:10.1371/journal.pone.0022877.g006
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Rab7, cathepsin D, LAMP1, and LAMP2 were obtained from
Abcam. Rab 5 antibody was purchased from Cell Signaling
Technology and Rab 9 antibody from Novus Biologicals. Alexa
Fluor 488 goat anti-mouse and goat anti-rabbit affinity-purified
antibodies were purchased from Invitrogen.
Expression and purification of rCARDS toxin
rCARDS toxin was expressed in BL21 DE3 (LpxM) [54],
purified using nickel column chromatography (Qiagen), and
desalted using PD10 desalting columns (GE Healthcare) as
previously described by us [17]. Similarly expressed and purified
M. pneumoniae recombinant EF-Tu and recombinant pyruvate
dehydrogenase ß subunit proteins were used as negative controls
[17].
Mammalian cell growth conditions
HeLa (CCL-2), Vero (CCL-81), CHO-K1 (CCL-61), and A549
(CCL-185) cells were obtained from the American Type Culture
Collection (ATCC). HeLa and Vero cells were passaged in
Minimal Essential Medium (MEM) (ATCC) with 10% fetal bovine
serum (FBS) (Atlas Biologicals). CHO-K1 (CCL-61) and A549
(CCL-185) cells were passaged in F-12K medium (ATCC) with
10% FBS. All cell lines were maintained at 37uCi n5 %C O 2 in
75 cm
2 flasks (Corning).
rCARDS toxin-induced vacuolation of mammalian cell
lines
Mammalian cell lines were grown in T25 cm
2 flasks (Corning)
and incubated in the presence or absence of rCARDS toxin at
varying concentrations and time intervals at 37uC. Cell vacuola-
tion was visualized using inverted light (Olympus CK 40) or
differential interference contrast (DIC) microscopy (Carl-Zeiss Cell
Observer).
Quantification of rCARDS toxin-induced vacuolation by
NRU
The NRU assay was performed as described with slight
modification [55]. Briefly, HeLa cells were seeded in 96-well
plates at a concentration of 4610
4 ml
21 for 24 h, before addition
of rCARDS toxin at varying concentrations (5 mgt o7 5mgm l
21)
for different time points. For specific experiments, HeLa cells were
pre-incubated with nocodazole (250 ng ml
21) and colchicine
(10 mM) for 1 h before addition of 50 mgm l
21 rCARDS toxin for
24 h at 37uC. Then, MEM culture medium was aspirated from
HeLa cells, and 100 ml of neutral red solution (40 mg ml
21 neutral
red prepared in phosphate buffered saline [PBS pH 7.4], filter
sterilized and diluted 1:100 in MEM medium) were added to each
well. Incubation was continued for 2 h at 37uC; cells were washed
with PBS; neutral red was extracted with 150 ml of destain solution
(50% ethanol, 49% distilled water, and 1% glacial acetic acid); and
OD550 nm was determined using a microtiter plate reader
spectrophotometer (Opsys MR, Dynex Technologies Inc.). NRU
was also measured in the presence and absence of monensin and
bafilomycin A1.
Cytochemical staining of rCARDS toxin-induced
vacuolation
Movement and localization of Lucifer yellow carbohydrazide
into vacuoles were assessed by incubating HeLa cells in the
presence of 75 mgm l
21 rCARDS toxin and 500 mgm l
21 Lucifer
yellow in MEM medium for 24 h at 37uC. Cells were washed with
PBS, fixed in 2% paraformaldehyde (methanol free, Electron
Microscopy Sciences) in PBS, and visualized with DIC and 488
filter sets using a Carl Zeiss Cell Observer Z.1 microscope
operated by a multichannel acquisition system (AXIO Vision
ver.4.7.2). Small and large vacuoles enriched with Lucifer yellow
were counted (.500 vacuoles counted) to analyze the percentage
of vacuoles associated with Lucifer yellow.
Immunofluorescence analysis of endosomal membrane
markers localized to rCARDS toxin-induced vacuoles
HeLa cells were seeded in 4-chamber glass slides (Lab-Tek II
Chambered #1.5 Borosilicate Coverglass, Fisher) at a concentra-
tion of 5610
4 cells/chamber 24 h before intoxication. Then, cells
were incubated in the presence or absence of 75 mgm l
21
rCARDS toxin for 24 h at 37uC. Cells were washed once with
PBS, fixed in 2% paraformaldehyde (methanol free) in PBS for
15 min at room temperature (RT), washed with PBS; and
permeabilized in 0.2% Triton X-100 in PBS for 5 min. Cells
were again washed in PBS with 1% normal goat serum (NGS,
GIBCO) and incubated with primary antibodies diluted 1:100
(EEA1, Rab 5, Rab 7, Rab 9, Cathepsin D, LAMP1, and LAMP2)
in PBS with 0.2% NGS for 1 h. Cells were washed with PBS
containing 0.2% NGS and incubated with secondary antibodies
diluted 1:500 (Alexa Fluor 488 goat anti-mouse or goat anti-rabbit)
in PBS with 0.2% NGS for 1 h at RT. Cells were washed again
with PBS and visualized with DIC and 488 filter sets using a Carl-
Zeiss Cell Observer Z.1 microscope.
Comparative immunoblot analysis of endosomal
membrane markers in rCARDS toxin-treated and
untreated HeLa cells
HeLa cells grown in T25 cm
2 flasks were incubated in the
presence or absence of 75 mgm l
21 rCARDS toxin for 24 h at
37uC. After visual detection of vacuolation by light microscopy,
HeLa cells were washed and scraped into PBS, and protein
concentrations were determined by bicinchoninic acid (BCA)
quantitation (Pierce). Intoxicated and non-intoxicated HeLa cells
were boiled in SDS-PAGE loading buffer, and total cell protein
(2 mg/well) was separated by gel electrophoresis on 4–12%
NuPAGE gels and transferred to nitrocellulose membranes.
Membranes were blocked in 5% blotto in Tris-Buffered Saline-
Tween-20 (TBST) for 1 h at RT. Primary antibodies were diluted
1:100 in 3% blotto in TBST and incubated with membranes for
1 h. Secondary goat anti-rabbit (Zymed) and goat anti-mouse
antibodies (Zymed) were diluted in TBST at 1:3000.
Immunoelectron microscopic analysis of rCARDS toxin-
treated HeLa cells
HeLa cells grown in T25 cm
2 flasks were intoxicated with 75 mg
ml
21 rCARDS toxin or buffer alone and incubated overnight at
37uC. HeLa cells were washed with PBS and fixed with 1%
glutaraldehyde/4% formaldehyde for 2 h at RT. Then, cells were
scraped into fixative and sections prepared and mounted on
Formvar-coated nickel grids. Individual grids were blocked with
100 mM Tris-HCl containing 1% BSA and 1% NGS and
incubated with antibodies reactive against Rab7 (rabbit polyclonal;
1:10 dilution) or Rab9 (mouse monoclonal; 1:10 dilution) in PBS
containing 1% BSA. After three washes in PBS with 1% BSA,
grids were incubated with secondary goat anti-rabbit 20 nm gold
particles (Rab7) and goat anti-mouse 10 nm gold particles (Rab9)
antibodies diluted 1:10 in PBS with 1% BSA. Individual grids were
analyzed with a JEOL 1230 transmission electron microscope at
an 80-kV accelerating voltage after staining with 7% uranyl
acetate followed by Reynold’s lead citrate.
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negative (DN) Rab7 and Rab9 in HeLa cells
HeLa cells were seeded in 4-chamber glass slides at a
concentration of 5610
4 cells/chamber for 24 h at 37uC prior to
transfection. Cells were either transfected with pEGFP-rab7 WT
(Addgene plasmid 12605), pEGFP-rab9 WT (Addgene plasmid
12663), DsRed-rab9 DN (Addgene plasmid 12676), or DsRed-
rab7 DN (Addgene plasmid 12662) [56] using FuGENE 6
transfection reagent (Roche) according to manufacturer’s instruc-
tions. Twenty-four h after transfection, cells were intoxicated with
75 mgm l
21 rCARDS toxin, incubated for another 24 h, and
washed with PBS. Cells were visualized with DIC and 488 or 633
filter sets using a Carl Zeiss Cell Observer Z.1 microscope.
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